JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
JAK抑制剂可降低SARS-CoV-2的肝脏感染性,并调节炎症反应以降低发病率和死亡率。
期刊:Science Advances
影响因子:11.7
doi:10.1126/sciadv.abe4724
Justin Stebbing,Ginés Sánchez Nievas,Marco Falcone,Sonia Youhanna,Peter Richardson,Silvia Ottaviani,Joanne X Shen,Christian Sommerauer,Giusy Tiseo,Lorenzo Ghiadoni,Agostino Virdis,Fabio Monzani,Luis Romero Rizos,Francesco Forfori,Almudena Avendaño Céspedes,Salvatore De Marco,Laura Carrozzi,Fabio Lena,Pedro Manuel Sánchez-Jurado,Leonardo Gianluca Lacerenza,Nencioni Cesira,David Caldevilla Bernardo,Antonio Perrella,Laura Niccoli,Lourdes Sáez Méndez,Daniela Matarrese,Delia Goletti,Yee-Joo Tan,Vanessa Monteil,George Dranitsaris,Fabrizio Cantini,Alessio Farcomeni,Shuchismita Dutta,Stephen K Burley,Haibo Zhang,Mauro Pistello,William Li,Marta Mas Romero,Fernando Andrés Pretel,Rafaela Sánchez Simón-Talero,Rafael García-Molina,Claudia Kutter,James H Felce,Zehra F Nizami,Andras G Miklosi,Josef M Penninger,Francesco Menichetti,Ali Mirazimi,Pedro Abizanda,Volker M Lauschke